Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InMed Pharmaceuticals (INM) Interest & Investment Income: 2022-2025

Historic Interest & Investment Income for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to $155,882.

  • InMed Pharmaceuticals' Interest & Investment Income rose 64.23% to $93,765 in Q3 2025 from the same period last year, while for Sep 2025 it was $192,553, marking a year-over-year decrease of 57.11%. This contributed to the annual value of $155,882 for FY2025, which is 70.47% down from last year.
  • Latest data reveals that InMed Pharmaceuticals reported Interest & Investment Income of $155,882 as of FY2025, which was down 70.47% from $527,901 recorded in FY2024.
  • Over the past 5 years, InMed Pharmaceuticals' Interest & Investment Income peaked at $527,901 during FY2024, and registered a low of $96,090 during FY2022.
  • Moreover, its 3-year median value for Interest & Investment Income was $492,440 (2023), whereas its average is $392,074.
  • Per our database at Business Quant, InMed Pharmaceuticals' Interest & Investment Income skyrocketed by 412.48% in 2023 and then tumbled by 70.47% in 2025.
  • InMed Pharmaceuticals' Interest & Investment Income (Yearly) stood at $96,090 in 2022, then surged by 412.48% to $492,440 in 2023, then climbed by 7.20% to $527,901 in 2024, then plummeted by 70.47% to $155,882 in 2025.